BVXV

BiondVax Pharmaceuticals Share Price - BVXV

42.47
1.57 (3.84%)
Upgrade to Real-Time
Afterhours (Closed)
42.47
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
BiondVax Pharmaceuticals Ltd BVXV NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
1.57 3.84% 42.47 18:00:22
Close Price Low Price High Price Open Price Previous Close
42.47 39.00 42.56 41.17 40.90
Bid Price Ask Price Spread News
39.00 48.00 9.00 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume
735 62,726  40.33  2,529,656 72,966
Last Trade Time Type Quantity Stock Price Currency
16:41:35 1  42.47 USD

BiondVax Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 489.56M 11.53M 11.53M  -  - -3.82 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% - -

more financials information »

News BiondVax Pharmaceuticals

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

BVXV Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.


Your Recent History
NASDAQ
BVXV
BiondVax P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.